Axsome Therapeutics, Inc. (AXSM)
206.68
-1.67
(-0.80%)
USD |
NASDAQ |
Sep 04, 16:00
206.96
+0.28
(+0.14%)
After-Hours: 20:00
Axsome Therapeutics SG&A Expense (TTM) : 712.66M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 712.66M |
| March 31, 2026 | 634.81M |
| December 31, 2025 | 570.60M |
| September 30, 2025 | 514.57M |
| June 30, 2025 | 459.90M |
| March 31, 2025 | 433.18M |
| December 31, 2024 | 411.36M |
| September 30, 2024 | 384.90M |
| June 30, 2024 | 372.52M |
| March 31, 2024 | 347.90M |
| December 31, 2023 | 323.12M |
| September 30, 2023 | 297.81M |
| June 30, 2023 | 255.52M |
| March 31, 2023 | 207.74M |
| December 31, 2022 | 159.25M |
| September 30, 2022 | 116.58M |
| June 30, 2022 | 95.92M |
| March 31, 2022 | 81.10M |
| December 31, 2021 | 66.65M |
| September 30, 2021 | 58.18M |
| June 30, 2021 | 44.28M |
| March 31, 2021 | 35.18M |
| Date | Value |
|---|---|
| December 31, 2020 | 28.90M |
| September 30, 2020 | 23.76M |
| June 30, 2020 | 20.54M |
| March 31, 2020 | 15.75M |
| December 31, 2019 | 13.60M |
| September 30, 2019 | 10.67M |
| June 30, 2019 | 9.765M |
| March 31, 2019 | 9.759M |
| December 31, 2018 | 9.352M |
| September 30, 2018 | 9.003M |
| June 30, 2018 | 8.626M |
| March 31, 2018 | 7.931M |
| December 31, 2017 | 7.207M |
| September 30, 2017 | 7.075M |
| June 30, 2017 | 6.888M |
| March 31, 2017 | 6.674M |
| December 31, 2016 | 6.344M |
| September 30, 2016 | 4.525M |
| June 30, 2016 | 2.886M |
| March 31, 2016 | 1.357M |
| December 31, 2015 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.24B |
| Liquidia Corp. | 192.66M |
| Filana Therapeutics, Inc. | 30.32M |
| CorMedix, Inc. | 138.00M |
| Eloxx Pharmaceuticals, Inc. | 6.133M |